Condition
Endovenous Laser Ablation
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05001776Phase 4Completed
Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein
NCT02017106Not ApplicableCompleted
Concomitant or Sequential Phlebectomy After Endovenous Laser Therapy for Varicose Veins
NCT03946644Not ApplicableUnknown
Safety Distance for Endovenous Laser Ablation of the Great Saphenous Vein
Showing all 3 trials